Medical device companies often fly under the radar of individual investors. That's a shame, as medical device companies have unique attributes that can make them wonderful long-term holdings.
Consider ShockWave Medical (NASDAQ: SWAV), a newly public company focused on cardiovascular disease. This innovator is commercializing a new type of therapy that has no direct competition, and it's growing at a triple-digit rate.
I was recently given an exclusive interview with Doug Godshall, ShockWave's president and CEO, to learn more about his company and the opportunity ahead. Below are some of the highlights from our conversation. (Some quotes have been edited for clarity.)